Find a Cancer Program  Log in to MyNetwork
Facebook  LinkedIn  Twitter  ACCC Youtube Channel

Search Drug Alphabetically

Generic Name Benztropine mesylate
Payment Category Medicare Part B
Year Introduced 1959
Type of Drug Synthetic compound with structural features found in atropine and diphenhydramine
Billing Unit 1 mg
Medicare Payment Limit (Effective January 1, 2021) $17.16

FDA-Approved Indication(s)

  • For use as an adjunct in the therapy of all forms of parkinsonism. Also useful in the control of extrapyramidal disorders due to neuroleptic drugs. (4/22/13)

Approved Indication(s) with Orphan Drug Status None
ICD-10 Code(s) for Labeled Indication(s) Parkinsons disease [G20.xx]; Other extrapyramidal and movement disorders [G25.x]
Name Strength Form Package Labeler NDC

Copyright © 2021 Association of Community Cancer Centers. All Rights Reserved.
11600 Nebel Street, Suite 201, Rockville, MD 20852  |  Tel.: 301.984.9496  |  Fax: 301.770.1949